<?xml version="1.0" encoding="UTF-8"?>
<p>Respiratory viruses including influenza viruses, respiratory syncytial virus (RSV), human rhinoviruses (HRV), human metapneumovirus (HMPV), parainfluenza viruses, adenovirus (ADV) and human bocavirus (BoV) are responsible for approximately 35–87% of ARIs in children [
 <xref rid="B15-vaccines-07-00168" ref-type="bibr">15</xref>,
 <xref rid="B16-vaccines-07-00168" ref-type="bibr">16</xref>,
 <xref rid="B17-vaccines-07-00168" ref-type="bibr">17</xref>]. Viral co-infections occur in 4–33% of children hospitalized with ARIs [
 <xref rid="B18-vaccines-07-00168" ref-type="bibr">18</xref>,
 <xref rid="B19-vaccines-07-00168" ref-type="bibr">19</xref>]. Bacterial infections caused by 
 <italic>S. pneumoniae</italic> and 
 <italic>H. influenzae</italic> may commonly be observed in the later stages of respiratory diseases [
 <xref rid="B20-vaccines-07-00168" ref-type="bibr">20</xref>]. The incidence of respiratory viral/bacterial co-infection in young children ranges from 1% to 44% [
 <xref rid="B21-vaccines-07-00168" ref-type="bibr">21</xref>], and studies on influenza pandemics over the last 100 years have strengthened the association of bacterial super-infections and influenza infections [
 <xref rid="B2-vaccines-07-00168" ref-type="bibr">2</xref>,
 <xref rid="B22-vaccines-07-00168" ref-type="bibr">22</xref>]. In addition, pertussis and measles still represent serious medical issues with lower respiratory tract involvement in several countries.
</p>
